HRT and Medical Weight Loss After Menopause: What New Research Shows
HRT and Medical Weight Loss After Menopause: What New Research Shows
Can hormone replacement therapy affect how women respond to medical weight loss after menopause?
New research is raising an interesting question about the relationship between menopause hormone therapy, weight loss, and metabolic health.
For women struggling with weight changes during perimenopause and menopause, this research is particularly important because it reinforces something we are increasingly recognizing in midlife medicine:
Hormonal health and metabolic health are deeply connected.
But there is an important distinction.
Hormone replacement therapy (HRT) is not a weight-loss treatment, and current research does not prove that taking hormones will make someone lose more weight.
What emerging evidence does suggest is that the hormonal environment after menopause may influence metabolic health, and potentially how some women respond to medical weight-loss treatment.
BOOK YOUR DISCOVERY CALL →
Serving patients in Seal Beach, CA and throughout California.
What Did the New Mayo Clinic Study Find?
A 2026 study published in The Lancet Obstetrics, Gynaecology, & Women's Health examined postmenopausal women with overweight or obesity undergoing medical weight-loss treatment.
Researchers analyzed data from the Mayo Clinic Health System and compared women who were using systemic menopausal hormone therapy with women who were not.
The study included 120 postmenopausal women:
40 women using systemic menopause hormone therapy
80 matched women who were not using hormone therapy
The researchers matched participants based on several factors, including age, BMI, age and type of menopause, previous obesity-medication use, and diabetes status.
At the last follow-up, women using hormone therapy experienced an average total body-weight reduction of approximately 19.2%, compared with approximately 14.0% among women who were not using hormone therapy.
That is a difference of approximately 5.2 percentage points between the groups.
Both groups also experienced improvements in several cardiometabolic measures, including glycemic measures, blood pressure, and liver enzymes.
The hormone-therapy group additionally demonstrated reductions in diastolic blood pressure, triglycerides, and AST.
The medication studied was tirzepatide, a medication used in obesity management. I mention the medication here specifically because it is part of the published research being discussed, not as a recommendation or representation of a medication offered by Core Function Health.
Read the published study (PMID pending, DOI: 10.1016/S3050-5038(25)00145-1)
Does This Mean HRT Causes More Weight Loss?
No, and this may be the most important part of the study to understand.
This was a retrospective observational cohort study, not a randomized controlled trial.
Researchers identified an association between concurrent menopause hormone therapy and greater weight loss. They did not establish that hormone therapy caused the additional weight loss.
There could be other differences between the women taking hormone therapy and those who were not that contributed to their outcomes.
The study was also relatively small, with 120 women included, and the majority of participants were White.
The researchers concluded that prospective randomized controlled trials are needed to determine whether a causal relationship exists.
So the appropriate takeaway is:
Women using menopausal hormone therapy experienced greater weight loss in this study, but we do not yet know whether hormone therapy itself was responsible.
That distinction matters.
Why Might Hormones Influence Metabolic Health?
The findings are particularly interesting because menopause affects much more than menstrual cycles.
The menopause transition is associated with changes in body composition and fat distribution, including an increased tendency toward abdominal and visceral fat accumulation and age-related loss of lean muscle.
Estrogen receptors are present throughout the body, and declining estrogen can influence multiple aspects of metabolic physiology.
Research has associated the menopausal transition with changes involving:
Visceral and abdominal fat
Lean muscle mass
Insulin sensitivity
Lipid metabolism
Fat oxidation
Sleep
Cardiovascular risk
A 2025 review examining menopause and body composition describes the menopausal transition as a period associated with redistribution of adipose tissue toward the abdomen and reductions in skeletal muscle mass and strength.
Read the review on PubMed (PMID: 40489975)
This helps explain why many women reach their 40s or 50s and feel like:
"I'm doing the same things I used to do, but my body isn't responding the same way anymore."
There can be real physiologic changes occurring during this stage of life.
But hormones are only one piece of the puzzle.
Age, genetics, nutrition, physical activity, sleep, stress, medications, thyroid function, insulin resistance, and loss of skeletal muscle can all influence weight and metabolic health.
That is why midlife weight changes shouldn't automatically be blamed on estrogen, or treated with hormones alone.
Is HRT a Weight-Loss Treatment?
No.
Hormone replacement therapy should not be prescribed simply because someone wants to lose weight.
Menopause hormone therapy may be considered for appropriate patients experiencing symptoms or conditions related to the menopausal transition after an individualized evaluation of symptoms, medical history, risks, benefits, and treatment goals.
Depending on the individual, HRT may be considered for concerns such as:
Hot flashes
Night sweats
Menopause-related sleep disruption
Genitourinary symptoms
Other appropriate symptoms associated with menopause
Research suggests hormone therapy may also influence aspects of body composition and metabolic physiology.
However:
Weight loss is not the primary indication for HRT.
This distinction is especially important as conversations about HRT and weight loss become more common online.
Where Does Medical Weight Loss Fit In?
For patients who meet appropriate clinical criteria, medical weight management can be another tool within a comprehensive metabolic health plan.
Modern medical weight-loss treatments can influence biological pathways involved in appetite, satiety, food intake, glucose regulation, and energy balance.
This matters because obesity is much more complicated than willpower.
During midlife, treating excess weight without considering the physiologic changes occurring during perimenopause and menopause may overlook important pieces of the metabolic picture.
Likewise, treating menopausal symptoms without evaluating metabolic and cardiovascular health can miss another important part of healthy aging.
The two conversations can, and often should, overlap.
Can HRT and Medical Weight Loss Be Used Together?
For appropriately selected patients, treatment of menopausal symptoms and medical management of weight may occur at the same time.
But they are treating different clinical concerns.
HRT may address appropriate symptoms and physiologic changes associated with menopause.
Medical weight management addresses overweight, obesity, appetite regulation, and metabolic health when clinically appropriate.
One does not automatically replace the other.
The Mayo Clinic study is particularly interesting because it raises the possibility that the hormonal environment may influence treatment response.
And it isn't the only research to raise this question.
A previous study published in Menopause evaluated weight-loss response in postmenopausal women with and without hormone-therapy use. That research also found greater weight loss among women using menopausal hormone therapy during treatment.
Read the study on PubMed (PMID: 38421683)
A more recent clinical review examining menopause hormone therapy and weight management discusses the growing evidence surrounding estrogen, body composition, energy expenditure, appetite regulation, and obesity treatment.
Read the clinical review on PubMed Central
Taken together, this research raises an intriguing question:
Could the hormonal environment influence a woman's metabolic response to medical weight-loss treatment?
Possibly.
But we do not yet have enough evidence to say that HRT enhances medical weight loss or that women should begin hormone therapy for this purpose.
More prospective research is needed.
Medical Weight Loss Shouldn't Be Just About the Scale
One of the biggest concerns with any weight-loss strategy during midlife is focusing exclusively on body weight.
Women are already vulnerable to age- and menopause-associated loss of lean muscle mass.
Significant weight loss can involve loss of both fat and lean tissue.
That is why a comprehensive medical weight-management strategy should also consider:
Adequate protein intake
Resistance training
Preservation of lean muscle
Appropriate nutrition
Sleep optimization
Metabolic health
Cardiovascular risk
Nutritional deficiencies when appropriate
Sustainable long-term weight maintenance
The goal shouldn't simply be becoming smaller.
The bigger goal is improving body composition, metabolic health, strength, and long-term health.
Why Comprehensive Evaluation Matters
When a woman tells me that she is gaining weight despite doing "everything right," I don't automatically assume that she needs HRT, or medical weight-loss treatment.
There may be multiple factors contributing at the same time.
Depending on symptoms, medical history, medications, and individual risk factors, an evaluation may include assessment of:
Metabolic Health
Glucose regulation, insulin resistance, hemoglobin A1c, and other metabolic markers may be considered when clinically appropriate.
Thyroid Health
Thyroid function may be evaluated based on symptoms, medical history, and previous laboratory results.
Cardiovascular Health
Traditional lipid testing and additional cardiovascular risk markers may be appropriate depending on an individual's history and risk factors.
Nutritional Status
Iron, vitamin B12, vitamin D, and other nutritional markers may be considered when clinically indicated.
Hormone Health
Hormonal evaluation should be guided by menopausal stage, menstrual history, symptoms, current hormone use, medical history, and the clinical question being addressed.
More testing is not automatically better.
The goal is to order the right testing for the right patient and interpret those results within the context of the whole person.
HRT, Medical Weight Loss and Muscle: The Midlife Conversation We Need to Be Having
Midlife health isn't just about estrogen.
And it isn't just about weight.
A more comprehensive approach asks:
What is happening to your metabolic health as hormones, muscle mass, fat distribution, sleep, insulin sensitivity, and cardiovascular risk change with age?
For one woman, improving sleep and treating menopausal symptoms may be the priority.
For another, insulin resistance and visceral adiposity may require more attention.
Another woman may be an appropriate candidate for medical weight management.
And some women may have several of these concerns occurring simultaneously.
There is no single protocol that is appropriate for everyone.
Why This Matters for Women in Perimenopause and Menopause
For years, women's weight concerns during midlife have often been reduced to some version of:
Eat less. Exercise more.
But human physiology is more complicated than that.
A woman in her 40s or 50s may simultaneously be experiencing changes in:
Estrogen, muscle mass, visceral fat, insulin sensitivity, sleep, appetite regulation, and cardiovascular risk.
Looking at only one of those factors can miss the bigger picture.
Likewise, treating hormones without considering metabolic health, or treating weight without considering the menopause transition, may overlook important contributors to how a woman feels and responds to treatment.
The emerging research surrounding HRT and medical weight loss doesn't give us all the answers yet.
But it does reinforce why menopause and metabolic health should not be treated as completely separate conversations.
Personalized Hormone & Medical Weight Management in Seal Beach and Throughout California
At Core Function Health, based in Seal Beach, CA, I provide an individualized approach for women navigating perimenopause, menopause, hormone changes, metabolic health, healthy aging, and medical weight management.
For women considering hormone replacement therapy, evaluation goes beyond simply checking a hormone level. Symptoms, menstrual and menopause history, medical history, appropriate laboratory testing, cardiovascular and metabolic risk factors, and individual treatment goals all help inform the conversation.
The same individualized approach applies to medical weight management.
Rather than focusing exclusively on BMI or the number on the scale, I believe it is important to consider the broader metabolic picture, including muscle preservation, insulin resistance, cardiovascular risk, sleep, nutrition, and hormonal health when appropriate.
Core Function Health serves patients in Seal Beach, Rossmoor, Los Alamitos, Long Beach, Orange County, and throughout California.
Ready to Learn More?
If you're experiencing unexplained weight changes, difficulty losing weight, changes in body composition, fatigue, sleep disruption, hot flashes, or other symptoms of perimenopause or menopause, a comprehensive evaluation can help determine what may be contributing and which treatment options may be appropriate for you.
Book a complimentary discovery call with Core Function Health to discuss your concerns, learn more about my approach, and determine whether we're a good fit for your health goals.
BOOK A DISCOVERY CALL →
Available to patients located in Seal Beach, CA and serving Long Beach, Huntington Beach, Los Alamitos, and throughout California.
Medical Disclaimer
This article is provided for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It does not constitute individualized medical advice. Hormone therapy and medical weight-management treatments have potential benefits, risks, contraindications, and side effects and are not appropriate for everyone. Individual treatment decisions should be made with a qualified healthcare professional following an appropriate medical evaluation.
References
Castaneda R, Bechenati D, Tama E, et al. The role of menopause hormone therapy in modulating tirzepatide-associated weight loss in postmenopausal women with overweight or obesity: a retrospective cohort study. The Lancet Obstetrics, Gynaecology, & Women's Health. 2026;2(2):e118-e128. View the published study
Hurtado MD, Tama E, Fansa S, et al. Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use. Menopause. 2024;31(4):266-274. Read on PubMed (PMID: 38421683)
Juppi HK, Karppinen JE, Laakkonen EK. Menopause and Body Composition: A Complex Field. Seminars in Reproductive Medicine. 2025. Read on PubMed (PMID: 40489975)
Clinical Review: Menopause Hormone Therapy in Weight Management. 2026. Read on PubMed Central